Gynecologic and Obstetric Investigation
Original Article
Increased Toll-Like Receptor-Myeloid Differentiation Factor 88 Expression at the Maternal-Fetal Interface Is Associated with Spontaneous AbortionHe M.a · Zhou Y.a, b · Jiang M.a, c · Li F.a · Yang M.a · Fan Y.a · Deng D.aaDepartment of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, bDepartment of Reproductive Medical Center, Tangdu Hospital, The Fourth Military Medical University, Xi'an, and cDepartment of Gynecology and Obstetrics, Northern Jiangsu Province Hospital, Clinical Medical College, Yangzhou University, Yangzhou, PR China
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: July 04, 2016
Accepted: March 06, 2017
Published online: June 14, 2017
Issue release date: November 2017
Number of Print Pages: 10
Number of Figures: 5
Number of Tables: 1
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Abstract
Aims: Toll-like receptors (TLRs) form a group of pattern recognition receptors that play a major role in maintaining innate host immunity. Myeloid differentiation factor 88 (MyD88) is an adaptor molecule that is essential for signaling via the TLR family. To analyze the mechanism of the imbalance in the innate immune system mediated by TLRs-MyD88 in spontaneous abortion, we detected the expression of TLR-2, TLR-4, TLR-7, and MyD88 in placentae and deciduas. Methods: The expression of TLR-2, TLR-4, TLR-7, and MyD88 in the placentae and deciduas of abortion-prone mice (n = 10) and normal pregnant mice (n = 10) were analyzed by immunochemistry, western blot, and real-time polymerase chain reaction. Results: There were higher protein expression levels of TLR-2, TLR-4, TLR-7, and MyD88 in the placentae and deciduas in the abortion-prone group than in the normal pregnant group. However, TLR-2, TLR-4, and TLR-7 showed lower gene expression, while MyD88 manifested higher gene expression in placentae and deciduas of abortion-prone mice matings. Conclusions: TLR-2, TLR-4, TLR-7, and MyD88 were expressed in the placenta and decidua of both the abortion-prone pregnant and normal pregnant mice. The overexpression of TLRs may excessively activate the innate immune system mediated by MyD88, which is considered to be related to the pathogenesis of spontaneous abortion.
© 2017 S. Karger AG, Basel
Related Articles:
References
-
Kwiatek M, Geca T, Krzyzanowski A, Malec A, Kwasniewska A: Peripheral dendritic cells and CD4+CD25+Foxp3+ regulatory T cells in the first trimester of normal pregnancy and in women with recurrent miscarriage. PLoS One 2015;10:e0124747.
-
Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al: Williams Obstetrics, ed 24. USA, MeGraw-Hill Education, 2014.
-
Practice Committee of American Society for Reproductive Medicine: Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2013;99:63.
-
Nigro G, Mazzocco M, Mattia E, Di Renzo GC, Carta G, Anceschi MM: Role of the infections in recurrent spontaneous abortion. J Matern Fetal Neonatal Med 2011;24:983-989.
-
Krieg S, Westphal L: Immune function and recurrent pregnancy loss. Semin Reprod Med 2015;33:305-312.
-
Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S: The role of inflammation and infection in preterm birth. Semin Reprod Med 2007;25:21-39.
-
Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
-
Loke YW, King A: Immunological aspects of human implantation. J Reprod Fertil Suppl 2000;55:83-90.
-
de Almeida LA, Carvalho NB, Oliveira FS, Lacerda TL, Vasconcelos AC, Nogueira L, et al: MyD88 and STING signaling pathways are required for IRF3-mediated IFN-β induction in response to Brucella abortus infection. PLoS One 2011;6:e23135.
-
Wang S, Cao C, Piao H, Li Y, Tao Y, Zhang X, et al: Tim-3 protects decidual stromal cells from toll-like receptor-mediated apoptosis and inflammatory reactions and promotes Th2 bias at the maternal-fetal interface. Sci Rep 2015;5:9013.
-
Guven-Maiorov E, Keskin O, Gursoy A, VanWaes C, Chen Z, Tsai CJ, et al: The architecture of the TIR domain signalosome in the toll-like receptor-4 signaling pathway. Sci Rep 2015;5:13128.
-
Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S: Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 2000;12:113-117.
-
Fazeli A, Bruce C, Anumba DO: Characterization of toll-like receptors in the female reproductive tract in humans. Human Reprod 2005;20:1372-1378.
-
Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, Romero R, et al: Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol 2004;173:4286-4296.
-
Tian T, Sun D, Wang P, Wang H, Bai X, Yang X, et al: Roles of toll-like receptor 7 and 8 in prevention of intrauterine transmission of hepatitis B virus. Cell Physiol Biochem 2015;37:445-453.
-
Filipovich Y, Lu SJ, Akira S, Hirsch E: The adaptor protein MyD88 is essential for E coli-induced preterm delivery in mice. Am J Obstet Gynecol 2009;200:93.e1-e8.
-
Lin Y, Ren L, Wang W, Di J, Zeng S, Saito S: Effect of TLR3 and TLR7 activation in uterine NK cells from non-obese diabetic (NOD) mice. J Reprod Immunol 2009;82:12-23.
-
Lin Y, Liu X, Shan B, Wu J, Sharma S, Sun Y: Prevention of CpG-induced pregnancy disruption by adoptive transfer of in vitro-induced regulatory T cells. PLoS One 2014;9:e94702.
-
Burrough ER, DiVerde KD, Sahin O, Plummer PJ, Zhang Q, Yaeger MJ: Expression of toll-like receptors 2 and 4 in subplacental trophoblasts from guinea pigs (Cavia porcellus) following infection with Campylobacter jejuni. Vet Pathol 2011;48:381-388.
-
Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al: Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-3752.
-
Abrahams VM, Visintin I, Aldo PB, Guller S, Romero R, Mor G: A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 2005;175:8096-8104.
-
Redecha P, van Rooijen N, Torry D, Girardi G: Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 2009;113:4101-4109.
-
Friebe A, Arck P: Causes for spontaneous abortion: what the bugs ‘gut' to do with it? Int J Biochem Cell Biol 2008;40:2348-2352.
-
Foerster K, He W, Manuel J, Bartczak A, Liu M, Markert UR, et al: LPS-induced occult loss in mice requires FGL2. Am J Reprod Immunol 2007;58:524-529.
-
Daher S, Mattar R, Gueuvoghlanian-Silva BY, Torloni MR: Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol 2012;67:341-347.
-
Lin Y, Li C, Shan B, Wang W, Saito S, Xu J, et al: Reduced stathmin-1 expression in natural killer cells associated with spontaneous abortion. Am J Pathol 2011;178:506-514.
-
Rai R, Regan L: Recurrent miscarriage. Lancet 2006;368:601-611.
-
Williams Z: Inducing tolerance to pregnancy. N Engl J Med 2012;367:1159-1161.
-
Patni S, Bryant AH, Wynen LP, Seager AL, Morgan G, Thornton CA: Functional activity but not gene expression of toll-like receptors is decreased in the preterm versus term human placenta. Placenta 2015;36:1031-1038.
-
Wang Z, Liu M, Nie X, Zhang Y, Chen Y, Zhu L, et al: NOD1 and NOD2 control the invasiveness of trophoblast cells via the MAPK/p38 signaling pathway in human first-trimester pregnancy. Placenta 2015;36:652-660.
-
Koga K, Izumi G, Mor G, Fujii T, Osuga Y: Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy complications. Am J Reprod Immunol 2014;72:192-205.
-
Amirchaghmaghi E, Taghavi SA, Shapouri F, Saeidi S, Rezaei A, Aflatoonian R: The role of toll like receptors in pregnancy. Int J Fertil Steril 2013;7:147-154.
-
Klaffenbach D, Rascher W, Rollinghoff M, Dotsch J, Meissner U, Schnare M: Regulation and signal transduction of toll-like receptors in human chorioncarcinoma cell lines. Am J Reprod Immunol 2005;53:77-84.
-
Holmlund U, Cebers G, Dahlfors AR, Sandstedt B, Bremme K, Ekstrom ES, et al: Expression and regulation of the pattern recognition receptors toll-like receptor-2 and toll-like receptor-4 in the human placenta. Immunology 2002;107:145-151.
-
Clark DA, Chaouat G, Banwatt D, Friebe A, Arck PC: Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA x DBA/2 mouse model: II. Fecal LPS levels in colonies with different basal abortion rates. Am J Reprod Immunol 2008;60:529-533.
-
de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C: Global signatures of protein and mRNA expression levels. Mol Biosyst 2009;5:1512-1526.
-
Land WG: The role of damage-associated molecular patterns in human diseases: part I - promoting inflammation and immunity. Sultan Qaboos Univ Med J 2015;15:e9-e21.
-
Mehmeti M, Allaoui R, Bergenfelz C, Saal LH, Ethier SP, Johansson ME, et al: Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer. Breast Cancer Res 2015;17:130.
-
Smith SC, Baker PN, Symonds EM: Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997;177:1395-1401.
-
Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186:158-166.
-
Huang Y, Yin H, Han J, Huang B, Xu J, Zheng F, et al: Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007;7:799-808.
-
Zhang JP, Yang Y, Levy O, Chen C: Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo. Pediatr Res 2010;68:479-483.
-
Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ: Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994;15:819-835.
-
Ho S, Winkler-Lowen B, Morrish DW, Dakour J, Li H, Guilbert LJ: The role of Bcl-2 expression in EGF inhibition of TNF-alpha/IFN-gamma-induced villous trophoblast apoptosis. Placenta 1999;20:423-430.
-
Crocker IP, Barratt S, Kaur M, Baker PN: The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts. Placenta 2001;22:822-830.
-
Yoo JH, Kwak-Kim J, Han AR, Ahn H, Cha SH, Koong MK, et al: Peripheral blood NK cell cytotoxicities are negatively correlated with CD8(+) T cells in fertile women but not in women with a history of recurrent pregnancy loss. Am J Reprod Immunol 2012;68:38-46.
-
Abrahams VM, Mor G: Toll-like receptors and their role in the trophoblast. Placenta 2005;26:540-547.
Article / Publication Details
Received: July 04, 2016
Accepted: March 06, 2017
Published online: June 14, 2017
Issue release date: November 2017
Number of Print Pages: 10
Number of Figures: 5
Number of Tables: 1
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission